Breaking News, Collaborations & Alliances

Fujifilm Cellular Dynamics and PhenoVista Biosciences Enter Drug Discovery Partnership

Enables access to services for phenotypic and high content screening imaging using iPSC-derived differentiated cells.

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Fujifilm Cellular Dynamics, Inc., a global developer and manufacturer of human induced pluripotent stem cell (iPSC) technologies, and PhenoVista Biosciences, a provider of custom imaging-based phenotypic assay services, entered a drug discovery partnership using iPSCs in screening. This alliance will enable drug discovery researchers and scientists access to services for phenotypic and high content screening (HCS) imaging using iPSC-derived differentiated cells, which are more biologically-relev...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters